Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endophthalmitis | 21 | 2025 | 122 | 5.460 |
Why?
|
| Eye Infections, Bacterial | 19 | 2025 | 129 | 4.800 |
Why?
|
| Bacillus cereus | 10 | 2025 | 59 | 2.690 |
Why?
|
| Staphylococcal Infections | 6 | 2025 | 87 | 2.580 |
Why?
|
| Staphylococcus aureus | 8 | 2025 | 121 | 2.320 |
Why?
|
| Gram-Positive Bacterial Infections | 13 | 2025 | 91 | 2.050 |
Why?
|
| Enterococcus faecalis | 10 | 2012 | 71 | 1.650 |
Why?
|
| Mice, Inbred C57BL | 20 | 2025 | 1653 | 1.440 |
Why?
|
| Immunity, Innate | 3 | 2025 | 231 | 1.070 |
Why?
|
| Mice | 23 | 2025 | 4802 | 1.050 |
Why?
|
| Cornea | 2 | 2025 | 72 | 0.950 |
Why?
|
| Blood-Retinal Barrier | 2 | 2016 | 27 | 0.950 |
Why?
|
| Retina | 9 | 2025 | 445 | 0.940 |
Why?
|
| Keratitis | 1 | 2025 | 31 | 0.930 |
Why?
|
| Disease Models, Animal | 13 | 2025 | 1507 | 0.890 |
Why?
|
| Bacterial Proteins | 8 | 2022 | 497 | 0.860 |
Why?
|
| Animals | 29 | 2025 | 10684 | 0.860 |
Why?
|
| Toll-Like Receptor 4 | 6 | 2025 | 72 | 0.820 |
Why?
|
| Virulence | 9 | 2023 | 153 | 0.750 |
Why?
|
| Genomic Islands | 4 | 2012 | 11 | 0.720 |
Why?
|
| Bacillus thuringiensis | 4 | 2021 | 19 | 0.650 |
Why?
|
| Bacterial Toxins | 3 | 2019 | 273 | 0.620 |
Why?
|
| Biomimetic Materials | 1 | 2019 | 20 | 0.600 |
Why?
|
| Nanostructures | 1 | 2019 | 64 | 0.570 |
Why?
|
| Virulence Factors | 3 | 2022 | 45 | 0.520 |
Why?
|
| Retinal Pigment Epithelium | 2 | 2020 | 99 | 0.500 |
Why?
|
| Retinal Vessels | 2 | 2016 | 75 | 0.480 |
Why?
|
| Inflammation | 6 | 2023 | 667 | 0.480 |
Why?
|
| Diabetic Retinopathy | 2 | 2016 | 112 | 0.450 |
Why?
|
| Toll-Like Receptor 2 | 6 | 2025 | 34 | 0.440 |
Why?
|
| Gene Expression Regulation, Bacterial | 6 | 2022 | 158 | 0.420 |
Why?
|
| Cytotoxins | 3 | 2004 | 51 | 0.400 |
Why?
|
| Chemokine CCL2 | 2 | 2024 | 47 | 0.400 |
Why?
|
| Conjugation, Genetic | 3 | 2010 | 11 | 0.400 |
Why?
|
| Plasmids | 4 | 2010 | 126 | 0.400 |
Why?
|
| Klebsiella Infections | 1 | 2012 | 12 | 0.390 |
Why?
|
| Erythrocytes | 2 | 2019 | 89 | 0.360 |
Why?
|
| Electroretinography | 7 | 2025 | 180 | 0.350 |
Why?
|
| Radiation Tolerance | 1 | 2010 | 28 | 0.320 |
Why?
|
| Ultraviolet Rays | 1 | 2010 | 40 | 0.320 |
Why?
|
| AraC Transcription Factor | 1 | 2008 | 5 | 0.290 |
Why?
|
| Cell Survival | 2 | 2016 | 419 | 0.290 |
Why?
|
| Membrane Glycoproteins | 2 | 2020 | 149 | 0.290 |
Why?
|
| Gene Transfer, Horizontal | 2 | 2009 | 10 | 0.280 |
Why?
|
| Chemokine CCL3 | 2 | 2024 | 9 | 0.260 |
Why?
|
| Chemokines, CXC | 2 | 2023 | 12 | 0.240 |
Why?
|
| Male | 6 | 2025 | 13921 | 0.240 |
Why?
|
| Mice, Knockout | 2 | 2025 | 874 | 0.230 |
Why?
|
| Leukocidins | 1 | 2025 | 4 | 0.230 |
Why?
|
| Cytokines | 4 | 2020 | 451 | 0.220 |
Why?
|
| Klebsiella pneumoniae | 2 | 2016 | 29 | 0.220 |
Why?
|
| Bacteriocins | 5 | 2010 | 18 | 0.220 |
Why?
|
| Humans | 16 | 2023 | 28851 | 0.210 |
Why?
|
| Prokaryotic Cells | 1 | 2003 | 3 | 0.210 |
Why?
|
| Eukaryotic Cells | 1 | 2003 | 10 | 0.210 |
Why?
|
| Phosphatidylcholines | 2 | 2020 | 45 | 0.210 |
Why?
|
| Rabbits | 2 | 2025 | 277 | 0.200 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 465 | 0.200 |
Why?
|
| Biofilms | 3 | 2022 | 122 | 0.190 |
Why?
|
| Genotype | 1 | 2023 | 461 | 0.190 |
Why?
|
| Bacillus | 1 | 2022 | 25 | 0.190 |
Why?
|
| Base Sequence | 4 | 2010 | 588 | 0.190 |
Why?
|
| Uveitis | 1 | 2022 | 23 | 0.190 |
Why?
|
| Pseudomonas Infections | 1 | 2022 | 25 | 0.180 |
Why?
|
| Chemokine CXCL2 | 1 | 2021 | 6 | 0.180 |
Why?
|
| Colony Count, Microbial | 4 | 2025 | 82 | 0.180 |
Why?
|
| Chemokine CXCL10 | 1 | 2021 | 22 | 0.180 |
Why?
|
| Chemokines | 2 | 2020 | 74 | 0.180 |
Why?
|
| Metalloproteases | 1 | 2021 | 7 | 0.180 |
Why?
|
| Metalloendopeptidases | 1 | 2021 | 40 | 0.170 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2022 | 72 | 0.170 |
Why?
|
| Female | 5 | 2025 | 15624 | 0.170 |
Why?
|
| Immunomodulation | 1 | 2019 | 20 | 0.150 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2020 | 101 | 0.150 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 37 | 0.150 |
Why?
|
| Nanotechnology | 1 | 2019 | 68 | 0.150 |
Why?
|
| Polymers | 1 | 2019 | 117 | 0.140 |
Why?
|
| Microarray Analysis | 1 | 2018 | 65 | 0.140 |
Why?
|
| Cells, Cultured | 2 | 2021 | 1022 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 1 | 2018 | 270 | 0.130 |
Why?
|
| Analysis of Variance | 1 | 2018 | 391 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 4 | 2025 | 536 | 0.130 |
Why?
|
| Genes, Bacterial | 2 | 2008 | 109 | 0.130 |
Why?
|
| Evans Blue | 1 | 2016 | 7 | 0.120 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2016 | 17 | 0.120 |
Why?
|
| Iodates | 1 | 2016 | 11 | 0.120 |
Why?
|
| Dextrans | 1 | 2016 | 23 | 0.120 |
Why?
|
| Angiography | 1 | 2016 | 35 | 0.120 |
Why?
|
| Coloring Agents | 1 | 2016 | 37 | 0.120 |
Why?
|
| Operon | 4 | 2005 | 40 | 0.120 |
Why?
|
| Neutrophils | 3 | 2021 | 183 | 0.120 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2015 | 31 | 0.120 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 465 | 0.110 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2019 | 82 | 0.110 |
Why?
|
| Molecular Sequence Data | 3 | 2008 | 1056 | 0.110 |
Why?
|
| Models, Animal | 2 | 2019 | 130 | 0.100 |
Why?
|
| Regulon | 1 | 2012 | 18 | 0.090 |
Why?
|
| Capillary Permeability | 1 | 2012 | 56 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 328 | 0.090 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2012 | 98 | 0.090 |
Why?
|
| Evolution, Molecular | 2 | 2009 | 85 | 0.080 |
Why?
|
| Physical Chromosome Mapping | 1 | 2010 | 8 | 0.080 |
Why?
|
| Pheromones | 1 | 2010 | 7 | 0.080 |
Why?
|
| Open Reading Frames | 1 | 2010 | 39 | 0.080 |
Why?
|
| Blood Platelets | 1 | 2012 | 206 | 0.080 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 1032 | 0.080 |
Why?
|
| Ependymoglial Cells | 2 | 2020 | 32 | 0.080 |
Why?
|
| Oligopeptides | 1 | 2010 | 97 | 0.080 |
Why?
|
| NF-kappa B | 2 | 2020 | 191 | 0.080 |
Why?
|
| DNA, Bacterial | 2 | 2006 | 309 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2009 | 245 | 0.070 |
Why?
|
| Chloramphenicol Resistance | 1 | 2006 | 3 | 0.060 |
Why?
|
| Stomach | 1 | 2006 | 43 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2006 | 87 | 0.060 |
Why?
|
| Recombination, Genetic | 1 | 2006 | 64 | 0.060 |
Why?
|
| Gastrointestinal Tract | 1 | 2006 | 35 | 0.060 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2019 | 133 | 0.060 |
Why?
|
| Gram-Positive Bacteria | 2 | 2005 | 33 | 0.060 |
Why?
|
| Macrophages | 1 | 2008 | 305 | 0.060 |
Why?
|
| Exotoxins | 1 | 2025 | 7 | 0.060 |
Why?
|
| Vitreous Body | 1 | 2025 | 23 | 0.060 |
Why?
|
| Lipid Bilayers | 1 | 2004 | 15 | 0.060 |
Why?
|
| Erythrocyte Membrane | 1 | 2004 | 23 | 0.060 |
Why?
|
| Surface Plasmon Resonance | 1 | 2004 | 37 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2004 | 44 | 0.060 |
Why?
|
| Hemolysis | 1 | 2004 | 51 | 0.060 |
Why?
|
| Peroxidase | 1 | 2024 | 39 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2025 | 209 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2025 | 292 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2025 | 128 | 0.050 |
Why?
|
| Models, Biological | 1 | 2004 | 469 | 0.050 |
Why?
|
| DNA Transposable Elements | 1 | 2002 | 34 | 0.050 |
Why?
|
| Adenosine Triphosphatases | 1 | 2022 | 50 | 0.040 |
Why?
|
| Life Style | 1 | 2022 | 91 | 0.040 |
Why?
|
| Bacteriophages | 1 | 2002 | 37 | 0.040 |
Why?
|
| Multiprotein Complexes | 1 | 2022 | 54 | 0.040 |
Why?
|
| Preservation, Biological | 1 | 2021 | 11 | 0.040 |
Why?
|
| Intravitreal Injections | 1 | 2021 | 34 | 0.040 |
Why?
|
| Eye | 1 | 2021 | 36 | 0.040 |
Why?
|
| HL-60 Cells | 1 | 2020 | 22 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 194 | 0.040 |
Why?
|
| Bacterial Adhesion | 1 | 2020 | 26 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 336 | 0.040 |
Why?
|
| Phagocytosis | 1 | 2020 | 80 | 0.040 |
Why?
|
| Drug Resistance, Microbial | 1 | 1999 | 36 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 1999 | 66 | 0.040 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2020 | 67 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1999 | 132 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 257 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 490 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2025 | 2426 | 0.040 |
Why?
|
| Antigens, Bacterial | 1 | 1999 | 165 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 1999 | 697 | 0.030 |
Why?
|
| Aqueous Humor | 1 | 2017 | 24 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2017 | 58 | 0.030 |
Why?
|
| Vitrectomy | 1 | 2016 | 8 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2016 | 115 | 0.030 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2015 | 12 | 0.030 |
Why?
|
| Peritonitis | 1 | 2012 | 15 | 0.020 |
Why?
|
| Phenotype | 1 | 2012 | 685 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2012 | 668 | 0.020 |
Why?
|
| Multigene Family | 1 | 2009 | 51 | 0.020 |
Why?
|
| Biomarkers | 1 | 2012 | 776 | 0.020 |
Why?
|
| Phylogeny | 1 | 2009 | 490 | 0.020 |
Why?
|
| Lysogeny | 1 | 2002 | 1 | 0.010 |
Why?
|
| Rhodococcus equi | 1 | 2002 | 2 | 0.010 |
Why?
|
| Gene Conversion | 1 | 2002 | 5 | 0.010 |
Why?
|
| Bacterial Capsules | 1 | 2002 | 9 | 0.010 |
Why?
|
| Streptococcus pneumoniae | 1 | 2002 | 29 | 0.010 |
Why?
|